drug

Med-eMonitor

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by The University of Texas Health Science Center at San Antonio
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BEHAVIORAL

Indications

Trials

1
Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia
NCT00406718—Completed

KOLs & investigators

1
Dawn I. Velligan, PhDKOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
The University of Texas Health Science Center at San Antonio
company
trial
Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia
NA
trial
indication
Schizophrenia
indication
Medication Adherence
indication
Schizophrenia
indication
Psychotic Disorders
indication
KOL
Dawn I. Velligan, PhD
KOL score 5
person